These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15871132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, Spector SA.
    J Infect Dis; 2003 Nov 15; 188(10):1461-72. PubMed ID: 14624371
    [Abstract] [Full Text] [Related]

  • 3. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL, Tierney C, Chang SY, D'Aquila RT, Bettendorf DM, Alexander HC, Santini CD, Hughes AM, Barroga CF, Spector SA, Landes JE, Hammer SM, Katzenstein DA.
    J Infect Dis; 2001 Dec 01; 184(11):1402-11. PubMed ID: 11709782
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
    Wichukchinda N, Nakayama EE, Rojanawiwat A, Pathipvanich P, Auwanit W, Vongsheree S, Ariyoshi K, Sawanpanyalert P, Shioda T.
    AIDS; 2006 Jan 09; 20(2):189-96. PubMed ID: 16511411
    [Abstract] [Full Text] [Related]

  • 5. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 6. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
    Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, Rowland-Jones SL.
    J Infect Dis; 1999 Oct 15; 180(4):1096-105. PubMed ID: 10479136
    [Abstract] [Full Text] [Related]

  • 7. [Distribution of HIV-1 coreceptor CX3CR1 allelic polymorphisms in general population, HIV-1 high-risk group and HIV-1 carriers of Chinese indigenous Han and Uygur people].
    Liu MX, Wang FS, Hong WG, Wang CQ, Wang B, Jin L, Hou J, Lei ZY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 15; 24(7):595-8. PubMed ID: 12975017
    [Abstract] [Full Text] [Related]

  • 8. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O, Huber K.
    Thromb Haemost; 2005 May 15; 93(5):949-54. PubMed ID: 15886814
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA, Lepri AC, Devereux H, Phillips AN, Loveday C, Lee CA.
    J Infect Dis; 2001 Aug 15; 184(4):511-4. PubMed ID: 11471111
    [Abstract] [Full Text] [Related]

  • 11. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y, Rubio C, Fernández E, Rubio M, Fibla J.
    J Infect Dis; 2001 Nov 15; 184(10):1279-88. PubMed ID: 11679916
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
    Paxton WA, Neumann AU, Kang S, Deutch L, Brown RC, Koup RA, Wolinsky SM.
    J Infect Dis; 2001 Jun 01; 183(11):1678-81. PubMed ID: 11343219
    [Abstract] [Full Text] [Related]

  • 14. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, EuroSIDA Study Group.
    J Infect Dis; 2005 Sep 15; 192(6):992-1002. PubMed ID: 16107951
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children.
    Kalish LA, McIntosh K, Read JS, Diaz C, Landesman SH, Pitt J, Rich KC, Shearer WT, Davenny K, Lew JF.
    J Infect Dis; 1999 Nov 15; 180(5):1514-20. PubMed ID: 10515810
    [Abstract] [Full Text] [Related]

  • 16. Baseline HIV type 1 coreceptor tropism predicts disease progression.
    Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM, Hemophilia Growth and Development Study.
    Clin Infect Dis; 2007 Sep 01; 45(5):643-9. PubMed ID: 17683002
    [Abstract] [Full Text] [Related]

  • 17. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Swiss HIV Cohort Study.
    Clin Infect Dis; 2005 Aug 01; 41(3):361-72. PubMed ID: 16007534
    [Abstract] [Full Text] [Related]

  • 18. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 19. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.
    AIDS; 2007 Nov 12; 21(17):2283-91. PubMed ID: 18090276
    [Abstract] [Full Text] [Related]

  • 20. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.
    AIDS; 2006 May 12; 20(8):1117-23. PubMed ID: 16691062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.